As frontier models converge and infrastructure commoditizes, power is shifting away from the AI itself and toward the platforms that control how agents are built, governed, and deployed. The next ...
Working with top global pharmaceutical sponsors, company doubles down on agentic AI and RBQM investments to bend the clinical development efficiency curveBOSTON--(BUSINESS WIRE)--eClinical Solutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results